Real time surveillance of COVID-19 space and time clusters during the summer 2020 in Spain.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
21 05 2021
Historique:
received: 26 01 2021
accepted: 28 04 2021
entrez: 21 5 2021
pubmed: 22 5 2021
medline: 26 5 2021
Statut: epublish

Résumé

On June 21st de-escalation measures and state-of-alarm ended in Spain after the COVID-19 first wave. New surveillance and control strategy was set up to detect emerging outbreaks. To detect and describe the evolution of COVID-19 clusters and cases during the 2020 summer in Spain. A near-real time surveillance system to detect active clusters of COVID-19 was developed based on Kulldorf's prospective space-time scan statistic (STSS) to detect daily emerging active clusters. Analyses were performed daily during the summer 2020 (June 21st - August 31st) in Spain, showing an increase of active clusters and municipalities affected. Spread happened in the study period from a few, low-cases, regional-located clusters in June to a nationwide distribution of bigger clusters encompassing a higher average number of municipalities and total cases by end-August. STSS-based surveillance of COVID-19 can be of utility in a low-incidence scenario to help tackle emerging outbreaks that could potentially drive a widespread transmission. If that happens, spatial trends and disease distribution can be followed with this method. Finally, cluster aggregation in space and time, as observed in our results, could suggest the occurrence of community transmission.

Sections du résumé

BACKGROUND
On June 21st de-escalation measures and state-of-alarm ended in Spain after the COVID-19 first wave. New surveillance and control strategy was set up to detect emerging outbreaks.
AIM
To detect and describe the evolution of COVID-19 clusters and cases during the 2020 summer in Spain.
METHODS
A near-real time surveillance system to detect active clusters of COVID-19 was developed based on Kulldorf's prospective space-time scan statistic (STSS) to detect daily emerging active clusters.
RESULTS
Analyses were performed daily during the summer 2020 (June 21st - August 31st) in Spain, showing an increase of active clusters and municipalities affected. Spread happened in the study period from a few, low-cases, regional-located clusters in June to a nationwide distribution of bigger clusters encompassing a higher average number of municipalities and total cases by end-August.
CONCLUSION
STSS-based surveillance of COVID-19 can be of utility in a low-incidence scenario to help tackle emerging outbreaks that could potentially drive a widespread transmission. If that happens, spatial trends and disease distribution can be followed with this method. Finally, cluster aggregation in space and time, as observed in our results, could suggest the occurrence of community transmission.

Identifiants

pubmed: 34016076
doi: 10.1186/s12889-021-10961-z
pii: 10.1186/s12889-021-10961-z
pmc: PMC8137313
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

961

Références

Am J Public Health. 1998 Sep;88(9):1377-80
pubmed: 9736881
Acta Trop. 2018 Sep;185:77-85
pubmed: 29709630
Int J Environ Res Public Health. 2020 Aug 14;17(16):
pubmed: 32824030
Appl Geogr. 2020 May;118:102202
pubmed: 32287518
Euro Surveill. 2020 Sep;25(35):
pubmed: 32885777
Am J Epidemiol. 1997 Jul 15;146(2):161-70
pubmed: 9230778
MMWR Morb Mortal Wkly Rep. 2020 May 08;69(18):
pubmed: 32379731
Spat Spatiotemporal Epidemiol. 2020 Aug;34:100354
pubmed: 32807396
Public Health Rep. 2006 Mar-Apr;121(2):133-9
pubmed: 16528945
PLoS Med. 2005 Mar;2(3):e59
pubmed: 15719066
Malar J. 2009 Apr 17;8:68
pubmed: 19374738

Auteurs

Nicolás Rosillo (N)

Servicio de Medicina Preventiva. Centro de Actividades Ambulatorias, 6ª planta, Bloque C, Hospital Universitario 12 de Octubre. Avenida de Córdoba, s/n, 28041, Madrid, Spain.
Centro Nacional de Epidemiología, Instituto de Salud Carlos IIII, Calle de Melchor Fernández Almagro 5, 28029, Madrid, Spain.

Javier Del-Águila-Mejía (J)

Centro Nacional de Epidemiología, Instituto de Salud Carlos IIII, Calle de Melchor Fernández Almagro 5, 28029, Madrid, Spain.
Servicio de Medicina Preventiva, Hospital Universitario de Móstoles, Calle Río Júcar, s/n, 28935, Móstoles, Spain.

Ayelén Rojas-Benedicto (A)

Centro Nacional de Epidemiología, Instituto de Salud Carlos IIII, Calle de Melchor Fernández Almagro 5, 28029, Madrid, Spain.
Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Calle Monforte de Lemos 3-5, 28029, Madrid, Spain.

María Guerrero-Vadillo (M)

Centro Nacional de Epidemiología, Instituto de Salud Carlos IIII, Calle de Melchor Fernández Almagro 5, 28029, Madrid, Spain.

Marina Peñuelas (M)

Centro Nacional de Epidemiología, Instituto de Salud Carlos IIII, Calle de Melchor Fernández Almagro 5, 28029, Madrid, Spain.

Clara Mazagatos (C)

Centro Nacional de Epidemiología, Instituto de Salud Carlos IIII, Calle de Melchor Fernández Almagro 5, 28029, Madrid, Spain.
Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Calle Monforte de Lemos 3-5, 28029, Madrid, Spain.

Jordi Segú-Tell (J)

Centro Nacional de Epidemiología, Instituto de Salud Carlos IIII, Calle de Melchor Fernández Almagro 5, 28029, Madrid, Spain.
Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Calle Monforte de Lemos 3-5, 28029, Madrid, Spain.

Rebeca Ramis (R)

Centro Nacional de Epidemiología, Instituto de Salud Carlos IIII, Calle de Melchor Fernández Almagro 5, 28029, Madrid, Spain. rramis@isciii.es.
Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Calle Monforte de Lemos 3-5, 28029, Madrid, Spain. rramis@isciii.es.

Diana Gómez-Barroso (D)

Centro Nacional de Epidemiología, Instituto de Salud Carlos IIII, Calle de Melchor Fernández Almagro 5, 28029, Madrid, Spain.
Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Calle Monforte de Lemos 3-5, 28029, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH